Alpha Tau Medical to Present at Multiple Investor Conferences
Ticker: DRTSW · Form: 6-K · Filed: Aug 22, 2024 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Aug 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-participation, investor-relations, press-release
TL;DR
Alpha Tau Medical is hitting up 4 investor conferences in Aug/Sept to talk shop.
AI Summary
Alpha Tau Medical Ltd. announced on August 22, 2024, that it will participate in four upcoming investor conferences: the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference. These appearances are intended to provide updates and engage with the investment community.
Why It Matters
Participation in these conferences allows Alpha Tau Medical to increase visibility with investors and potentially attract new funding or partnerships.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in conferences, which is routine and does not involve significant financial or operational changes.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- H.C. Wainwright (company) — Conference Organizer
- Sidoti (company) — Conference Organizer
- Redburn Atlantic (company) — Conference Organizer
- Rothschild & Co (company) — Conference Organizer
- Lytham Partners (company) — Conference Organizer
FAQ
Which specific conferences will Alpha Tau Medical Ltd. be participating in?
Alpha Tau Medical Ltd. will participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 22, 2024.
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K is to report the issuance of a press release announcing the company's participation in several investor conferences.
What is the exact name of the registrant?
The exact name of the registrant is Alpha Tau Medical Ltd.
What is the ticker symbol or commission file number for Alpha Tau Medical Ltd.?
The commission file number for Alpha Tau Medical Ltd. is 001-41316.
Filing Stats: 327 words · 1 min read · ~1 pages · Grade level 10.8 · Accepted 2024-08-22 08:32:25
Filing Documents
- ea0212064-6k_alphatau.htm (6-K) — 19KB
- ea021206401ex99-1_alphatau.htm (EX-99.1) — 17KB
- 0001213900-24-071625.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: August 22, 2024 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3